TLR4 and metabolic dysfunction-associated steatohepatitis: Rodent models of TLR4 deficiency consistently demonstrated reduced NASH‐related liver injury38 and TLR4 or CD14 (a TLR4 co‐receptor) polymorphisms in human have been linked to NASH development and severity in some studies.39